131 Results for "

IL13

" in MedChemExpress (MCE) Product Catalog:
Products (131)

131 Results for "IL13" in MCE Product Catalog:

Cat. No.: HY-P990741
CAS No.: 2648456-30-6
Synonyms: UCB-9741

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Galvokimig is an anti-IL13/IL17A/ALB/IL17B monoclonal antibody .
loading...
    loading...
Cat. No.: HY-P2797
CAS No.: 9001-06-3
Synonyms: AMCase, Serratia marcescens
Chitinase, Serratia marcescens is a chitinase from Serratia marcescens. Chitinase is a chitin-targeting enzyme with chitin hydrolysis activity. Chitinase inhibits chitin-induced innate type 2 inflammation in the lung. Chitinase augments chitin-free, allergen-induced Th2 inflammation. Chitinase mediates effector functions of IL-13 .
loading...
    loading...
Cat. No.: HY-P990699
CAS No.: 2641479-65-2
Synonyms: ZTS-00008183

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Riltovetbart is a canine-derived IgG2 κ monoclonal antibody raised against Canlupfam IL13 .
loading...
    loading...
Cat. No.: HY-P99883
CAS No.: 1399584-78-1
Synonyms: SAR156597
Romilkimab (SAR156597) is a humanized IG antibody that specifically targets IL-4 and IL-13. Romilkimab can be used for the research of diffuse cutaneous systemic sclerosis .
loading...
    loading...
Cat. No.: HY-P2797B
CAS No.: 9001-06-3
Research Areas:  

Inflammation/Immunology

Chitinase is a chitin-targeting enzyme with chitin hydrolysis activity. Chitinase inhibits chitin-induced innate type 2 inflammation in the lung. Chitinase augments chitin-free, allergen-induced Th2 inflammation. Chitinase mediates effector functions of IL-13 .
loading...
    loading...
Cat. No.: HY-P99870
CAS No.: 2445460-16-0
Synonyms: ASLAN004; CSL-334; MK-6105
Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Eblasakimab (ASLAN004) is a fully human monoclonal antibody that binds with high affinity to IL-13Rα1 (binds to IL-13Rα1 with a Kd of 453 pM). Eblasakimab reduces neuronal responses to IL-4, IL-13, and their combination . Eblasakimab can be used in research on atopic dermatitis .
loading...
    loading...
Cat. No.: HY-110295
CAS No.: 688347-51-5
Target:  

GSNOR

Research Areas:  

Inflammation/Immunology

SPL-334 is a potent and selective S-Nitrosoglutathione reductase (GSNOR) inhibitor. SPL-334 causes a significant reduction in the production of Th2 cytokines IL-5 and IL-13 and the levels of the chemokine CCL11 (eotaxin-1) in the airways. SPL-334 can be used in research of allergic airway inflammation .
loading...
    loading...
Cat. No.: HY-144683A
CAS No.: 2415317-57-4
Research Areas:  

Inflammation/Immunology

PF-07038124 hydrochloride is a PDE4 inhibitor with an IC50 of 0.5 nM for PDE4B2. PF-07038124 hydrochloride shows inhibitory activities against IL-13, IL4, and IFNγ (IC50=125, 4.1, 1.06 nM, respectively). PF-07038124 hydrochloride can be used for research of atopic dermatitis and plaque psoriasis .
loading...
    loading...
Cat. No.: HY-P99417
CAS No.: 2043952-59-4
Synonyms: UCB4144; VR 942

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Abrezekimab (UCB4144; VR 942) is a humanized, high-affinity, neutralizing anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents IL-13 binding to the IL-13 Rα1 subunit. Abrezekimab can be used for the research of asthma .
loading...
    loading...
Cat. No.: HY-162248
CAS No.: 3023876-01-6
Target:  

JAK Interleukin Related

Research Areas:  

Inflammation/Immunology Cancer

JAK1/2-IN-1 is a potent JAK1 and JAK2 inhibitor with IC50 values of 0.4 nM and 8.1 nM, respectively. JAK1/2-IN-1 also inhibits IL-4 and IL-13 with IC50s of 136.5 nM and 19.1 nM, respectively (WO2023244775A1; Example 33a) .
loading...
    loading...
Cat. No.: HY-144683
CAS No.: 2415085-44-6
Research Areas:  

Inflammation/Immunology

PF-07038124 is a PDE4 inhibitor with an IC50 of 0.5 nM for PDE4B2. PF-07038124 shows inhibitory activities against IL-13, IL4, and IFNγ (IC50=125, 4.1, 1.06 nM, respectively). PF-07038124 can be used for research of atopic dermatitis and plaque psoriasis .
loading...
    loading...
Cat. No.: HY-125019
CAS No.: 1831144-46-7
Purity:  99.86%
Target:  

JAK STAT

Research Areas:  

Inflammation/Immunology

iJak-381 is a JAK1/2 inhibitor with anti-inflammatory activity. iJak-381 blocks IL-13 signaling and also inhibits IL-4 and IL-6 signaling pathways. iJak-381 also reduced p-STAT6 levels and inhibited the influx of inflammatory cells into the lungs of mice. iJak-381 inhibits airway hyperresponsiveness (AHR) .
loading...
    loading...
Cat. No.: HY-RS06686
Research Areas:  

Others

Il13 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Il13 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS06685
Research Areas:  

Others

IL13 Human Pre-designed siRNA Set A contains three designed siRNAs for IL13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-174639
Target:  

mRNA

Research Areas:  

Inflammation/Immunology

Human IL13 mRNA encodes the human interleukin 13 (IL13) protein, an immunoregulatory cytokine produced primarily by activated Th2 cells. IL13 is involved in several stages of B-cell maturation and differentiation and is found to be critical to the pathogenesis of allergen-induced asthma but operates through mechanisms independent of IgE and eosinophils.
loading...
    loading...
Cat. No.: HY-P991150
CAS No.: 2981477-39-6

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Ompekimig is an immunoglobulin monoclonal antibody that targets IL-4, IL-13, IL-33. Ompekimig shows potential for use in immune-mediated inflammatory diseases such as asthma and atopic dermatitis .
loading...
    loading...
Cat. No.: HY-P991258

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

CNTO-5825 is a humanized monoclonal antibody inhibitor targeting interleukin-13 (IL-13). CNTO-5825 is promising for research of Th2-type inflammatory related diseases such as asthma and atopic dermatitis .
loading...
    loading...
Cat. No.: HY-RS06687
Research Areas:  

Others

Il13 Rat Pre-designed siRNA Set A contains three designed siRNAs for Il13 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P991633

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

TQC2938 is a humanized IgG2 monoclonal antibody inhibitor targeting Stimulation-2 (ST2). TQC2938 inhibits the ST2/IL-33 signaling pathway, reduces the level of downstream Th2 cytokines (such as IL-4, IL-5, and IL-13) and eosinophils as well as other inflammatory cells. TQC2938 can be used for inflammatory diseases like asthma research .
loading...
    loading...
Cat. No.: HY-P11147
CAS No.: 2319573-67-4
Research Areas:  

Cancer

IL13Rα2 D1 is an effective IL-13/IL13Rα2 signaling axis inhibitor. IL13Rα2 D1 can inhibit IL-13-induced cell adhesion, migration, invasion, and proliferation. IL13Rα2 D1 can inhibit FAK, Src, AKT, ERK1/2 phosphorylation, and MMP expression. IL13Rα2 D1 can be used for research on cancers such as colorectal cancer .
loading...
    loading...